Oncology Innovation: Optimism & Obstacles
While the prospect of a cancer diagnosis understandably brings a range of emotions for everyone involved, there is considerable excitement throughout the oncology sector. Such optimism is being driven by breakthroughs in advanced therapy options and improved overall clinical outcomes in terms of progression-free survival across many different types of cancer. Ongoing efforts to both optimize trial enrollment and improve prescribing through the strategic use of genomic profiling, growth in the use of oral versus traditional infused oncology agents, and initiatives to address persistent diversity gaps and information gaps in the traditional randomized controlled trial (RCT) process also herald a bright future in this space.
For the full article, please visit Pharmaceutical Commerce.